$INFU Q2 '26 Earnings Results & Recap InfuSystem reaffirms 2026 full-year guidance, estimating pro-forma net revenue growth between 6% to 8% and continuing to forecast an Adjusted EBITDA margin in the mid to low 20% range.
$INFU Q2 '26 Earnings Results & Recap InfuSystem reaffirms 2026 full-year guidance, estimating pro-forma net revenue growth between 6% to 8% and continuing to forecast an Adjusted EBITDA margin in the mid to low 20% range.